BIOGEN INC. 10-Q filing
Filed 2025-07-31 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0000875045-25-000033
- Form type
- 10-Q
- CIK
- 0000875045
- Primary document
- https://www.sec.gov/Archives/edgar/data/875045/000087504525000033/biib-20250630.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BIOGEN INC..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $5.1B | - | - |
| Cost Of Revenue | $1.2B | - | - |
| Net Income | $875.3M | - | - |
| Eps Basic | 5.98 | - | - |
| Eps Diluted | 5.97 | - | - |
| Total Assets | $28.3B | - | - |
| Total Liabilities | $10.7B | - | - |
| Operating Cash Flow | $420.2M | - | - |
| Capital Expenditures | $63.7M | - | - |